Celebrating our 10th anniversary – Unlock our special offer today

Global health group calls for HnB restrictions until science is proven

A new position paper on heat-not-burn (HnB) products from the International Union Against Tuberculosis and Lung Disease suggests that advertising and indoor use should be banned while governments await independent science.

The Union, a global medical education and research organisation which focuses on low- and middle-income countries, says that “the current published literature on the health impact of HnB tobacco products is dominated by industry-sponsored research that unequivocally concludes that HnB tobacco products pose a lower risk than cigarettes”.

Therefore, it recommends, governments should “apply the precautionary principle to the regulation of HnB tobacco products. Countries should wait for independent assessment of the health effects of HnB tobacco products and not simply take industry assertions at face value.”

Among specific policy measures, it urges that “advertising, promotion, and sponsorship activities of HnB tobacco products should be banned”, as should indoor use, because “HnB tobacco products still pollute the air around people using the products, creating second-hand exposure”.

 

Subscribe to our Newsletter

Join in to hear about news, events, and podcasts in the sector

    See more

    What This Means: That The Union puts little trust in HnB is clear from its opening paragraph, where it states that both combustibles and electronic nicotine delivery systems (ENDS) “were introduced and promoted to maintain [tobacco] industry profits”, a comment whose stunning obviousness is paralleled only by its air of dismissive disdain.

    However, though The Union’s argument is shaped by preconceptions, it should not be disregarded.

    That most research on the new HnB category comes (so far) from the manufacturers was always going to be a problem. Even if the science itself is impeccable, the mere appearance of partiality could rebound on HnB’s reputation among regulators and health professionals, as this paper shows it is already doing.

    It’s worth observing that another recent report on HnB and health risks, from the UK’s Committee on Toxicity, was much more sanguine about passive exposure and indeed less alarmist in general, but also raised the issue of research. This nagging doubt is unlikely to go away until independent work starts to appear in volume.

    – Barnaby Page ECigIntelligence staff

    Barnaby Page

    Editorial director
    Before joining ECigIntelligence in early 2014 as one of its first employees, Barnaby had a 30-year career as a reporter and editor for newspapers, magazines and online services, working in Canada, the US and the Middle East as well as his current British location. He has edited publications covering fields including technology and the advertising industry, and was launch editor of the first large daily online news service in the British regional media. Barnaby also writes on classical music and film for a number of publications. Barnaby manages the editorial and reporting teams and works closely with the analyst teams, to ensure that all content meets high standards of quality and relevance. He also writes for the site occasionally, mostly on science-related issues, and is a member of the Association of British Science Writers.

    Our Key Benefits

    The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

    ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

    • Stay informed of any legal and market change in the sector that impacts your organisation
    • Maximise resources by getting market and legal data analysis daily in one place
    • Make smart decisions by understanding how the regulatory and market landscape evolves
    • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization